To date Mesa received $4.5 million in One Arizona settlement funds. The city will give $1 million to nonprofits working to ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

More New Yorkers received scripts for buprenorphine, a med used to treat opioid addiction, amid fight against record-high ...

A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug ...

New Monash University research has revealed a concerning rise in new opioid prescriptions among younger Victorians, while also finding an overall positive trend, with a drop in opioid prescription ...

A federal appeals court axed a $650 million judgment and corresponding injunction against CVS Pharmacy, Walgreens Boots ...

Journavx is a newly-aproved painkiller that experts say could help Long Island's opioid epidemic. NewsdayTV's Virginia Huie reports.

School district employees who administer the emergency antagonists in compliance with state law are immune from civil liability. CDC data points out that while overall fentanyl overdoses in the U.S.

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...